Lycopodium Limited
LYOPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $437 | $383 | $246 | $237 |
| - Cash | $79 | $68 | $82 | $101 |
| + Debt | $16 | $13 | $16 | $17 |
| Enterprise Value | $375 | $328 | $179 | $153 |
| Revenue | $334 | $345 | $324 | $229 |
| % Growth | -3.1% | 6.4% | 41.6% | – |
| Gross Profit | $308 | $312 | $80 | $42 |
| % Margin | 92.1% | 90.7% | 24.8% | 18.5% |
| EBITDA | $68 | $76 | $68 | $46 |
| % Margin | 20.3% | 22.2% | 21.1% | 20% |
| Net Income | $42 | $51 | $47 | $27 |
| % Margin | 12.6% | 14.7% | 14.4% | 11.9% |
| EPS Diluted | 1.06 | 1.28 | 1.18 | 0.68 |
| % Growth | -17.2% | 8.5% | 73.5% | – |
| Operating Cash Flow | $37 | $28 | $20 | $42 |
| Capital Expenditures | -$2 | -$1 | -$4 | -$4 |
| Free Cash Flow | $35 | $27 | $15 | $38 |